Wanbangde Pharmaceutical Group Co., Ltd
Clinical trials sponsored by Wanbangde Pharmaceutical Group Co., Ltd, explained in plain language.
A Chinese pharmaceutical company involved in drug development and manufacturing.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a natural compound slow Alzheimer's decline?
Disease control Recruiting nowThis trial is testing whether huperzine A, given as a controlled-release tablet, can improve thinking and daily living skills in people with mild-to-moderate Alzheimer's dementia. Participants will receive either huperzine A, a placebo, or an existing Alzheimer's drug (donepezil)…
Phase: PHASE2, PHASE3 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 18, 2026 08:00 UTC
-
Can a Three-Pronged therapy reboot the brain after injury?
Disease control Recruiting nowThis trial explores whether combining two medications—ginkgo leaf dropping pills and huperzine A injection—with a non-invasive nerve stimulation therapy can improve cognitive function in adults who have lasting thinking and memory problems after a brain injury. Participants will …
Phase: PHASE4 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 18, 2026 08:00 UTC